Log in
NASDAQ:BLUE

bluebird bio Price Target, Predictions & Analyst Ratings

$55.00
+0.45 (+0.82 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
$53.95
Now: $55.00
$56.23
50-Day Range
$51.65
MA: $55.84
$59.40
52-Week Range
$38.95
Now: $55.00
$99.36
Volume758,654 shs
Average Volume1.04 million shs
Market Capitalization$3.64 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.1

Analyst Ratings

bluebird bio (NASDAQ:BLUE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
19 Wall Street analysts have issued ratings and price targets for bluebird bio in the last 12 months. Their average twelve-month price target is $105.14, predicting that the stock has a possible upside of 91.17%. The high price target for BLUE is $160.00 and the low price target for BLUE is $68.00. There are currently 4 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
BLUE Consensus Rating: BuyBuyBuyBuy
BLUE Consensus Rating Score: 2.792.782.782.78
BLUE Analyst Ratings: 0 Sell Rating(s)
4 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
BLUE Consensus Price Target: $105.14$103.77$107.77$120.60
BLUE Price Target Upside: 91.17% upside61.17% upside62.73% upside50.19% upside

bluebird bio (NASDAQ:BLUE) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

bluebird bio (NASDAQ:BLUE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/19/2020MizuhoInitiated CoverageBuy$123.00Medium
8/31/2020OppenheimerInitiated CoverageBuy$111.00High
8/30/2020William BlairReiterated RatingHoldHigh
8/19/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
8/10/2020Morgan StanleyLower Price TargetEqual Weight$73.00 ➝ $68.00Medium
8/6/2020BMO Capital MarketsLower Price TargetOutperform$112.00 ➝ $108.00High
8/6/2020WedbushLower Price TargetOutperform$89.00 ➝ $81.00Medium
7/13/2020Bank of AmericaLower Price TargetBuy$104.00 ➝ $100.00High
6/12/2020SVB LeerinkBoost Price TargetOutperform$129.00 ➝ $133.00Medium
5/13/2020BarclaysReiterated RatingBuyHigh
5/12/2020Royal Bank of CanadaInitiated CoverageOutperform$100.00High
5/12/2020Canaccord GenuityReiterated RatingBuy$118.00High
5/11/2020Piper SandlerLower Price TargetNeutral$75.00 ➝ $70.00High
3/26/2020Stifel NicolausUpgradeHold ➝ Buy$94.00 ➝ $70.00Low
3/26/2020Wells Fargo & CompanyReiterated RatingBuyMedium
2/19/2020Raymond JamesDowngradeStrong-Buy ➝ Market PerformHigh
2/3/2020Evercore ISIUpgradeIn-Line ➝ Outperform$86.00 ➝ $100.00High
12/6/2019CowenReiterated RatingBuyLow
11/1/2019Maxim GroupReiterated RatingBuy$130.00Low
7/19/2019GabelliReiterated RatingBuyN/A
6/14/2019Piper Jaffray CompaniesSet Price TargetHold$120.00Low
5/16/2019SunTrust BanksLower Price TargetBuy$174.00Medium
3/22/2019Cantor FitzgeraldSet Price TargetHold$122.00Low
12/3/2018Janney Montgomery ScottSet Price TargetOutperform ➝ Buy$170.00High
11/14/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$155.00High
9/21/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyMedium
9/17/2018GuggenheimInitiated CoverageNeutralMedium
5/3/2018BTIG ResearchReiterated RatingBuyHigh
3/16/2018UBS GroupInitiated CoverageSellHigh
12/21/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformHigh
12/11/2017Jefferies Financial GroupUpgradeHold ➝ Buy$130.00 ➝ $211.00High
(Data available from 10/21/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.